Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04834778
Title A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors HiberCell, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
HealthPartners Cancer Care Center Saint Paul Minnesota 55101 United States Details
Baylor University Medical Center Dallas Texas 75246 United States Details
The University of Texas M.D. Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field